Vensana Capital I GP, LLC
SEC Form 4 insider trading activity
Vensana Capital I GP, LLC has filed 1 SEC Form 4 filing (5 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 10, 2026.
On the most recent filing, Vensana Capital I GP, LLC is listed as 10% Owner at SpyGlass Pharma, Inc. Inside the rolling window, Vensana Capital I GP, LLC reported 1 open-market purchase totaling $2.6M in SGP and no open-market sales.
Companies traded
Other insiders at SGP
Insider Buying
$2.6M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Vensana Capital I GP, LLC made?
Vensana Capital I GP, LLC has filed 1 SEC Form 4 filing (5 transaction rows) across 1 company since 2026.
Which companies does Vensana Capital I GP, LLC trade?
Vensana Capital I GP, LLC has filed SEC Form 4 disclosures for 1 company, including SGP.
When was Vensana Capital I GP, LLC's most recent SEC Form 4 filing?
Vensana Capital I GP, LLC's most recent SEC Form 4 filing on Tracefour is dated Feb 10, 2026.
What is Vensana Capital I GP, LLC's total buy and sell value in the current window?
Inside the rolling retention window, Vensana Capital I GP, LLC bought $2.6M and sold $0 based on SEC Form 4 filings.
What was Vensana Capital I GP, LLC's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 165,000 SGP shares on 2026-02-09, worth $2.6M, per SEC Form 4 filings.